Docoh
Loading...

AGN Allergan

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands andbest-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry.

Company profile

Ticker
AGN
Exchange
CEO
Brenton L. Saunders
Employees
Incorporated
Location
Fiscal year end
Former names
Actavis Ltd, Actavis plc
SEC CIK
Subsidiaries
AGN International Inc. • AGN Kythera, L.P. • AGN Labs LLC • AGN LLC • AGN Sundry LLC • Akarna Therapeutics, Limited • Allergan WC 1 S.a r.l. • Allergan (Chengdu) Medical Aesthetics Clinic Co., Ltd. • Allergan (Thailand) Limited • Allergan AG ...

AGN stock data

(
)

Calendar

7 May 20
28 Sep 21
31 Dec 21
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D No No 0 16,532 0 0
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D Yes No 0 9,538 0 16,542
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D Yes No 0 471 0 26,080
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No No 70.79 9,446 668.68K 0
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No No 73.14 3,691 269.96K 0
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No No 90.22 2,790 251.71K 0
8 May 20 William Meury RSU Sale back to company Dispose D No No 0 25,201 0 0
8 May 20 William Meury Ordinary Shares, par value $0.0001 Sale back to company Dispose D No No 0 7,434 0 0
8 May 20 William Meury Performance Stock Units Ordinary Shares Sale back to company Dispose D No No 0 26,506 0 0
8 May 20 William Meury Stock Options Ordinary Shares Sale back to company Dispose D No No 196.16 12,304 2.41M 0

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

5.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1 4 -75.0%
Opened positions 0 2 EXIT
Closed positions 3 1 +200.0%
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 3.52M EXIT
Total shares 16.99M 17.01M -0.1%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
GIC Private 16.99M $0 0.0%
IFP Advisors 0 $0
Largest transactions
Shares Bought/sold Change
ASB Associated Banc-Corp. 0 -15.5K EXIT
Penbrook Management 0 -4.12K EXIT
Founders Capital Management 0 -276 EXIT
GIC Private 16.99M 0 0.0%
IFP Advisors 0 0

Financial report summary

?
Competition
AkornTherapeuticsMDAMGENHologicVeruVivusRoyalty PharmaPalatinIntegra LifesciencesIRIDEX
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: alpha, API, argument, Asia, AstraZeneca, autoimmune, behavior, biodegradable, broadest, built, buyer, Cadila, certainty, chain, composition, confirm, confirming, contamination, continent, Coolsculpting, CoolTone, Cream, cystic, declare, deliver, detailing, discontinuation, discontinued, distancing, Durysta, electronic, enrolling, environment, enzyme, Esthetique, evolve, exocrine, experienced, Gedeon, genericization, glaucoma, globe, half, home, hypertension, inability, indirectly, inhibitor, innovation, insufficiency, intracameral, intraocular, IOP, Ireland, Lab, Lazeo, LIBOR, lifetime, local, logistical, losing, medial, minute, mitigate, Nestle, OAG, ocular, OHT, outbreak, Pacific, pancreatic, pandemic, patient, pressure, rebate, recession, recovery, relationship, remotely, reply, Richter, satisfaction, Science, shelter, spent, spread, strain, susceptible, suspended, temporarily, Ubrelvy, unemployment, Viokace, Vital
Removed: absence, acceleration, acid, add, adjunctive, advancement, affirming, Akorn, Akron, Apotex, appellate, applied, Argentum, asserting, authorize, automatically, back, binding, BioMed, Biomedical, Body, bound, buy, calculate, calculated, capitalized, capitalizing, Center, centralized, certiorari, chosen, clarify, cloud, collateralization, collateralized, commonly, computing, concurrently, Contouring, contractually, conversion, correct, corrected, Corrupt, cumulative, delaying, Delzicol, denial, denying, Depressive, dermatology, determining, Deva, disgorgement, Disorder, dozen, Easement, enablement, enacted, enforceable, Envy, equaled, equipment, equitable, error, established, estate, Europe, exemption, exercised, expedient, explicitly, Famy, fiscal, fleet, fourth, Framework, gamma, GILTI, ground, Harbor, HD, higher, hosted, immunity, implementation, implicit, implicitly, improper, incorrectly, India, Influenced, InnoPharma, institute, instrument, intent, invalidity, inventorship, issuing, joinder, LA, land, lease, leasing, Legacy, legally, lessee, lessor, Lidoderm, LifeCell, limit, Low, mandatorily, mandatory, MDD, modified, modify, noncancelable, notification, offsetting, older, opening, option, orphan, ownership, package, pattern, Pennsylvania, pension, permission, pertaining, Pharmacal, pivotal, plant, Plastic, postretirement, practical, preferred, prepaid, preventing, privately, pronouncement, prospectively, purpose, qualify, Racketeer, rapastinel, rating, reaching, real, receptor, reclassification, reclassify, recognition, redeemed, refinancing, released, remove, renew, renewal, rental, Replacement, represented, requiring, residual, restitution, resurfacing, retinoic, retired, retrospective, retrospectively, revaluation, reversing, RORyt, ROU, SA, scaling, shortened, skin, Slayback, software, sovereign, standalone, statutory, stranded, substantive, substitute, Subtopic, suit, supplier, Surgery, suspension, Targeted, Taxed, TCJA, terminate, Therapy, threshold, topline, treble, tribal, TWi, Ubrogepant, unrelated, updated, USD, vendor, VI, Vitae, withdraw, withdrew, writ